fingolimod has been researched along with bay 11-7082 in 1 studies
Studies (fingolimod) | Trials (fingolimod) | Recent Studies (post-2010) (fingolimod) | Studies (bay 11-7082) | Trials (bay 11-7082) | Recent Studies (post-2010) (bay 11-7082) |
---|---|---|---|---|---|
65 | 0 | 51 | 570 | 1 | 383 |
Protein | Taxonomy | fingolimod (IC50) | bay 11-7082 (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.82 | |
Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 2 | |
Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 2 | |
Transcription factor p65 | Homo sapiens (human) | 2.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, E; Ekins, S; Foil, DH; Havener, TM; Hickey, AJ; Makarov, V; Monakhova, N; Puhl, AC; Rank, L; Riabova, O; Zorn, KM | 1 |
1 other study(ies) available for fingolimod and bay 11-7082
Article | Year |
---|---|
Multiple approaches to repurposing drugs for neuroblastoma.
Topics: Bayes Theorem; Cell Line, Tumor; Child; Child, Preschool; Crizotinib; Drug Repositioning; Etoposide; Fingolimod Hydrochloride; Humans; Neuroblastoma; Niclosamide | 2022 |